It is very interesting to observe that classical treatment, such as atropine to control myopia progression, which seemed to have its effect over the accommodation to reduce the axial growth of the eye, really is controlled by a regulator of G-protein signaling (RGS). This evidence concerns the gene PITX2 and myopia.